Registration of securities issued in business combination transactions

Commitments and Contingencies (Details)

v3.23.2
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies (Details) [Line Items]          
Rent expense for space $ 13,080        
Rent expense   $ 100,000 $ 100,000 $ 400,000 $ 400,000
Royalties ranging percentage   8.00%      
Sublicense sales percentage   12.00%      
2011 Exclusive Agreement [Member]          
Commitments and Contingencies (Details) [Line Items]          
Milestone payment       $ 765,000  
License reduced percentage       50.00%  
Aggregate maintenance fees       $ 80,000  
Maintenance fees annually       $ 50,000  
Percentage of worldwide net sales       2.00%  
Subject to a minimum royalty payment       $ 75,000  
Royalty description       The Company is required to pay royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of Phase II clinical trials) to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of Phase I clinical trials).  
2013 Exclusive Agreement [Member]          
Commitments and Contingencies (Details) [Line Items]          
Milestone payment   $ 765,000   $ 765,000  
License reduced percentage   50.00%   50.00%  
Percentage of worldwide net sales   2.00%   2.00%  
Subject to a minimum royalty payment   $ 75,000   $ 75,000  
Royalty description       The Company is required to pay the Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of Phase II clinical trials) to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of Phase I clinical trials).  
Initial license issue fee   10,000   $ 10,000  
Aggregate maintenance fees   7,500   7,500  
Maintenance fees annually   $ 5,000   $ 5,000